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Good news from the DoH!
The columns of the newspapers and of the SAMJ have fre-
quently voiced despair at the controversial and mixed mes-
sages emanating from the Department of National Health. The 
refreshingly positive speech (p. 1159) by the Deputy Minister of 
Health, Mrs Nozizwe Madlala-Routledge, at the South African 
Medical Association Presidential Dinner therefore augurs well 
for co-operation between the profession and the department. 
The Deputy Minister called for a close relationship between 
the Department of Health and all its partners in the public and 
private medical spheres. The central task that brings us together 
is that of improving the quality of care for all our people. She 
acknowledged the divisions on the treatment of HIV/AIDS, in 
which there is a perceived battle between modern and tradi-
tional medical science. While respecting the role of traditional 
medicine and the need to put more resources into its research, 
she deplored the charlatans who rob our people and expose 
them to unnecessary early death by luring them away from the 
established health system and promising them instant cures. 
SAMA as a professional medical association can play an in-
fluential role because of the close interaction of its practitioners 
with patients, medical knowledge and experience. She identi-
fied the importance of SAMA in directing some of its resources 
towards developing a policy resource centre. 
Particularly heartening was the Deputy Minister’s emphasis 
on the importance of medical science for helping us to find 
solutions to our medical problems. She stressed the importance 
of evidence-based research and that our policy decisions must 
always be guided by the best available scientific knowledge, 
derived from credible, peer-reviewed research.
Human papillomavirus progress
Human papillomavirus (HPV) is a very common sexually trans-
mitted virus and is causally associated with cervical cancer. 
Bruce Allan and colleagues (p. 1186) explored the agreement 
between cervical abnormalities identified by cytology and 
detection of high-risk types of HPV. 
HPV types infecting the genital tract are broadly divided into 
high- and low-risk types on the basis of their association with 
cervical cancer. The low-risk types are causally associated with 
genital warts. Pooled data from case-controlled studies showed 
that 15 types were classified as high-risk types and a further 3 
were probable high-risk types. The Papanicolaou (Pap) smear 
test is the standard cytology screening method test used world-
wide. It is inexpensive and simple but is only moderately ac-
curate. The Digene Hybrid Capture 2 high-risk test (HC2) is the 
only commercially available assay system for HPV detection. 
The authors found that HC2 detected a high prevalence of 
HPV (17%) in the population that they studied. Most women 
with high-grade squamous intraepithelial lesions (83%) were 
positive, indicating that HPV testing could aid in the manage-
ment of women with abnormal squamous cells of unknown 
significance. When costs decrease, HC2 could be introduced as 
an adjunct to Pap smears in identifying women at risk for high-
grade cervical disease and could be helpful in the maintenance 
of those who remain Pap smear-negative. 
A further important advance is that the development of vac-
cines showing protection against incident and persistent HPV-
16 and HPV-18 infections, and incident HPV-31 and HPV-45 
infections, is advanced. 
Rural doctor honoured
His peers have voted Dr Vanga Siwisa Rural Doctor of the Year 
(Chris Bateman, p. 1154). The award is in recognition of his Her-
culean task of currently consulting close to 100 ARV patients 
per day. 
Siwisa is an apartheid-era exile who qualified as a doctor in 
Lagos in 1977. He arrived at the 300-bed Taung District Hospi-
tal, which serves a huge community in North West province, 
in 2004. He was initially frightened by encountering the first 
minor side-effects to antiretroviral drugs in view of the health 
minister and government’s pronouncements on the side-effects 
of these drugs. Siwisa believes that the award belongs to his 
entire clinic staff, who ‘work like mad’. Inspiration comes from 
seeing those who came in on wheelchairs and stretchers, happy, 
smiling and up and about.
Termination of Pregnancy Act reduces 
morbidity
The Choice on Termination of Pregnancy Act came into effect in 
1996. Mbele, Snyman and Pattinson report on their studies on 
the impact of this Act on maternal morbidity and mortality in 
the West of Pretoria (p. 1196).
They found that the introduction of the Choice on Termi-
nation of Pregnancy Act has been associated with a massive 
reduction in women presenting with incomplete abortions. The 
prevalence of critically ill women due to complications of abor-
tion has not changed, but the case fatality rate, mortality index 
and maternal mortality ratio have declined significantly.
Hypertension Guideline challenged 
The recently published South African Hypertension Guideline 
(S Afr Med J 2006; 96: 337-362) provides a comprehensive review 
of the causes, risks and treatment associated with abnormal 
blood pressure. Gaziano (p. 1170) argues that it falls short of 
offering a cost-effective approach to managing the burden. He 
proposes, inter alia, that the South African Hypertension Society 
could improve its guidelines by adopting a threshold for treat-
ment based on global clinical risk.
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